A citation-based method for searching scientific literature

C L Scherr, N M Lindor, T L Malo, F J Couch, S T Vadaparampil. Clin Genet 2015
Times Cited: 17







List of co-cited articles
48 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.
Sue Richards, Nazneen Aziz, Sherri Bale, David Bick, Soma Das, Julie Gastier-Foster, Wayne W Grody, Madhuri Hegde, Elaine Lyon, Elaine Spector,[...]. Genet Med 2015
52

The counsellees' view of an unclassified variant in BRCA1/2: recall, interpretation, and impact on life.
Joël Vos, Wilma Otten, Christi van Asperen, Anna Jansen, Fred Menko, Aad Tibben. Psychooncology 2008
80
35

A preliminary investigation of genetic counselors' information needs when receiving a variant of uncertain significance result: a mixed methods study.
Courtney L Scherr, Noralane M Lindor, Teri L Malo, Fergus J Couch, Susan T Vadaparampil. Genet Med 2015
18
35

Understanding of BRCA VUS genetic results by breast cancer specialists.
B K Eccles, E Copson, T Maishman, J E Abraham, D M Eccles. BMC Cancer 2015
53
35

Distress among women receiving uninformative BRCA1/2 results: 12-month outcomes.
Suzanne C O'Neill, Christine Rini, Rachel E Goldsmith, Heiddis Valdimarsdottir, Lawrence H Cohen, Marc D Schwartz. Psychooncology 2009
70
35


Opening the psychological black box in genetic counseling. The psychological impact of DNA testing is predicted by the counselees' perception, the medical impact by the pathogenic or uninformative BRCA1/2-result.
Joël Vos, Encarna Gómez-García, Jan C Oosterwijk, Fred H Menko, Reinoud D Stoel, Christi J van Asperen, Anna M Jansen, Anne M Stiggelbout, Aad Tibben. Psychooncology 2012
48
29

Variants of uncertain significance in BRCA testing: evaluation of surgical decisions, risk perception, and cancer distress.
J O Culver, C D Brinkerhoff, J Clague, K Yang, K E Singh, S R Sand, J N Weitzel. Clin Genet 2013
57
23


Variants of unknown significance in BRCA testing: impact on risk perception, worry, prevention and counseling.
S Richter, I Haroun, T C Graham, A Eisen, A Kiss, E Warner. Ann Oncol 2013
60
23

Clinical evaluation of a multiple-gene sequencing panel for hereditary cancer risk assessment.
Allison W Kurian, Emily E Hare, Meredith A Mills, Kerry E Kingham, Lisa McPherson, Alice S Whittemore, Valerie McGuire, Uri Ladabaum, Yuya Kobayashi, Stephen E Lincoln,[...]. J Clin Oncol 2014
303
17

Multiplex genetic testing for cancer susceptibility: out on the high wire without a net?
Susan M Domchek, Angela Bradbury, Judy E Garber, Kenneth Offit, Mark E Robson. J Clin Oncol 2013
156
17


Clinical characteristics affect the impact of an uninformative DNA test result: the course of worry and distress experienced by women who apply for genetic testing for breast cancer.
Sandra van Dijk, Daniëlle R M Timmermans, Hanne Meijers-Heijboer, Aad Tibben, Christi J van Asperen, Wilma Otten. J Clin Oncol 2006
60
17

Variants of uncertain clinical significance as a result of BRCA1/2 testing: impact of an ambiguous breast cancer risk message.
Sandra van Dijk, Christi J van Asperen, Catharina E Jacobi, Geraldine R Vink, Aad Tibben, Martijn H Breuning, Wilma Otten. Genet Test 2004
32
17

BRCA1 and BRCA2 genetic testing-pitfalls and recommendations for managing variants of uncertain clinical significance.
D M Eccles, G Mitchell, A N A Monteiro, R Schmutzler, F J Couch, A B Spurdle, E B Gómez-García. Ann Oncol 2015
109
17

A taxonomy of medical uncertainties in clinical genome sequencing.
Paul K J Han, Kendall L Umstead, Barbara A Bernhardt, Robert C Green, Steven Joffe, Barbara Koenig, Ian Krantz, Leo B Waterston, Leslie G Biesecker, Barbara B Biesecker. Genet Med 2017
52
17


Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles.
Sheila Seal, Deborah Thompson, Anthony Renwick, Anna Elliott, Patrick Kelly, Rita Barfoot, Tasnim Chagtai, Hiran Jayatilake, Munaza Ahmed, Katarina Spanova,[...]. Nat Genet 2006
487
11

NSGC practice guideline: risk assessment and genetic counseling for hereditary breast and ovarian cancer.
Janice L Berliner, Angela Musial Fay, Shelly A Cummings, Brittany Burnett, Todd Tillmanns. J Genet Couns 2013
78
11

Gene-panel sequencing and the prediction of breast-cancer risk.
Douglas F Easton, Paul D P Pharoah, Antonis C Antoniou, Marc Tischkowitz, Sean V Tavtigian, Katherine L Nathanson, Peter Devilee, Alfons Meindl, Fergus J Couch, Melissa Southey,[...]. N Engl J Med 2015
488
11

Development of a tiered and binned genetic counseling model for informed consent in the era of multiplex testing for cancer susceptibility.
Angela R Bradbury, Linda Patrick-Miller, Jessica Long, Jacquelyn Powers, Jill Stopfer, Andrea Forman, Christina Rybak, Kristin Mattie, Amanda Brandt, Rachelle Chambers,[...]. Genet Med 2015
52
11

Decision making with uncertain information: learning from women in a high risk breast cancer clinic.
Caren J Frost, Vickie Venne, Dianne Cunningham, Ruth Gerritsen-McKane. J Genet Couns 2004
32
11

Utilization of multigene panels in hereditary cancer predisposition testing: analysis of more than 2,000 patients.
Holly LaDuca, A J Stuenkel, Jill S Dolinsky, Steven Keiles, Stephany Tandy, Tina Pesaran, Elaine Chen, Chia-Ling Gau, Erika Palmaer, Kamelia Shoaepour,[...]. Genet Med 2014
208
11

Tolerance for uncertainty and perceived risk among women receiving uninformative BRCA1/2 test results.
Suzanne C O'Neill, Tiffani DeMarco, Beth N Peshkin, Sarah Rogers, Jessica Rispoli, Karen Brown, Heiddis Valdimarsdottir, Marc D Schwartz. Am J Med Genet C Semin Med Genet 2006
49
11

Family communication matters: the impact of telling relatives about unclassified variants and uninformative DNA-test results.
Joël Vos, Anna M Jansen, Fred Menko, Christi J van Asperen, Anne M Stiggelbout, Aad Tibben. Genet Med 2011
26
11

Subjective interpretation of inconclusive BRCA1/2 cancer genetic test results and transmission of information to the relatives.
C Cypowyj, F Eisinger, L Huiart, H Sobol, M Morin, C Julian-Reynier. Psychooncology 2009
20
11

Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer: A Joint Consensus Recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists.
Marilyn M Li, Michael Datto, Eric J Duncavage, Shashikant Kulkarni, Neal I Lindeman, Somak Roy, Apostolia M Tsimberidou, Cindy L Vnencak-Jones, Daynna J Wolff, Anas Younes,[...]. J Mol Diagn 2017
520
11

A new initiative on precision medicine.
Francis S Collins, Harold Varmus. N Engl J Med 2015
11

Point-counterpoint. Ethics and genomic incidental findings.
Amy L McGuire, Steven Joffe, Barbara A Koenig, Barbara B Biesecker, Laurence B McCullough, Jennifer S Blumenthal-Barby, Timothy Caulfield, Sharon F Terry, Robert C Green. Science 2013
128
11

Primary care providers' cancer genetic testing-related knowledge, attitudes, and communication behaviors: A systematic review and research agenda.
Jada G Hamilton, Ekland Abdiwahab, Heather M Edwards, Min-Lin Fang, Andrew Jdayani, Erica S Breslau. J Gen Intern Med 2017
45
11

Translational advances regarding hereditary breast cancer syndromes.
M Gage, D Wattendorf, L R Henry. J Surg Oncol 2012
57
11

Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results.
Sharon E Plon, Diana M Eccles, Douglas Easton, William D Foulkes, Maurizio Genuardi, Marc S Greenblatt, Frans B L Hogervorst, Nicoline Hoogerbrugge, Amanda B Spurdle, Sean V Tavtigian. Hum Mutat 2008
542
11

Comparative effectiveness of screening and prevention strategies among BRCA1/2-affected mutation carriers.
Victor R Grann, Priya R Patel, Judith S Jacobson, Ellen Warner, Daniel F Heitjan, Maxine Ashby-Thompson, Dawn L Hershman, Alfred I Neugut. Breast Cancer Res Treat 2011
68
11

Impact of Panel Gene Testing for Hereditary Breast and Ovarian Cancer on Patients.
Heidi S Lumish, Hallie Steinfeld, Carrie Koval, Donna Russo, Elana Levinson, Julia Wynn, James Duong, Wendy K Chung. J Genet Couns 2017
61
11

Gaps in Incorporating Germline Genetic Testing Into Treatment Decision-Making for Early-Stage Breast Cancer.
Allison W Kurian, Yun Li, Ann S Hamilton, Kevin C Ward, Sarah T Hawley, Monica Morrow, M Chandler McLeod, Reshma Jagsi, Steven J Katz. J Clin Oncol 2017
129
11


Lynch Syndrome Limbo: Patient Understanding of Variants of Uncertain Significance.
Ilana Solomon, Elizabeth Harrington, Gillian Hooker, Lori Erby, Jennifer Axilbund, Heather Hampel, Kara Semotiuk, Amie Blanco, William M P Klein, Francis Giardiello,[...]. J Genet Couns 2017
28
11

Effect on perceived control and psychological distress of genetic knowledge in women with breast cancer receiving a BRCA1/2 test result.
Anne Brédart, Jean-Luc Kop, Antoine De Pauw, Olivier Caron, Anne Fajac, Catherine Noguès, Dominique Stoppa-Lyonnet, Sylvie Dolbeault. Breast 2017
8
25

A comprehensive laboratory-based program for classification of variants of uncertain significance in hereditary cancer genes.
J M Eggington, K R Bowles, K Moyes, S Manley, L Esterling, S Sizemore, E Rosenthal, A Theisen, J Saam, C Arnell,[...]. Clin Genet 2014
115
11

Physicians' reactions to uncertainty in the context of shared decision making.
Mary C Politi, France Légaré. Patient Educ Couns 2010
43
11

A new definition of Genetic Counseling: National Society of Genetic Counselors' Task Force report.
Robert Resta, Barbara Bowles Biesecker, Robin L Bennett, Sandra Blum, Susan Estabrooks Hahn, Michelle N Strecker, Janet L Williams. J Genet Couns 2006
354
11

Assessment of the content and process of genetic counseling: a critical review of empirical studies.
Bettina Meiser, Jennifer Irle, Elizabeth Lobb, Kristine Barlow-Stewart. J Genet Couns 2008
95
11

Clinical Decision-Making in Patients with Variant of Uncertain Significance in BRCA1 or BRCA2 Genes.
Jessemae L Welsh, Tanya L Hoskin, Courtney N Day, Abigail S Thomas, Jodie A Cogswell, Fergus J Couch, Judy C Boughey. Ann Surg Oncol 2017
34
11

Perceiving cancer-risks and heredity-likelihood in genetic-counseling: how counselees recall and interpret BRCA 1/2-test results.
J Vos, J C Oosterwijk, E Gómez-García, F H Menko, A M Jansen, R D Stoel, C J van Asperen, A Tibben, A M Stiggelbout. Clin Genet 2011
32
11

Variants of uncertain significance in breast cancer-related genes: real-world implications for a clinical conundrum. Part one: clinical genetics recommendations.
Susan Miller-Samuel, Deborah J MacDonald, Jeffrey N Weitzel, Ferdy Santiago, Martin A Martino, Tara Namey, Annmarie Augustyn, Rebecca Mueller, Andrea Forman, Angela R Bradbury,[...]. Semin Oncol 2011
12
16

Assessing what to address in science communication.
Wändi Bruine de Bruin, Ann Bostrom. Proc Natl Acad Sci U S A 2013
57
11

The sciences of science communication.
Baruch Fischhoff. Proc Natl Acad Sci U S A 2013
72
11

The integration of next-generation sequencing panels in the clinical cancer genetics practice: an institutional experience.
Caitlin B Mauer, Sara M Pirzadeh-Miller, Linda D Robinson, David M Euhus. Genet Med 2014
52
5

Standards and guidelines for CFTR mutation testing.
Carolyn Sue Richards, Linda A Bradley, Jean Amos, Bernice Allitto, Wayne W Grody, Anne Maddalena, Matthew J McGinnis, Thomas W Prior, Bradley W Popovich, Michael S Watson,[...]. Genet Med 2002
78
5


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.